This review examines the evolution of bioprinting toward minimally invasive in situ strategies for internal organ regeneration. It defines the technological roadmap from handheld systems to advanced minimally invasive bioprinting platforms, positioning soft robotics as a core enabler.
Duc Tu Vu +9 more
wiley +1 more source
Evaluating international collaboration on horizon scanning for pharmaceuticals: developing key performance indicators for the international horizon scanning initiative. [PDF]
Leeneman B +3 more
europepmc +1 more source
Scalable Electrochemical Concrete Fabrication and Closed‐Loop Recycling
The electrochemical‐driven recycling strategy establishes a reversible concrete material flow by extracting Ca, Si, Al, and Fe from concrete waste and regenerating functional feedstocks. These reversed products are reassembled into new concrete, which re‐enters service and ultimately returns to waste, enabling a closed‐loop, waste‐origin, and low ...
Hanxiong Lyu +7 more
wiley +1 more source
Labour market patterns among women and men following the uptake of their first parental leave benefit in Sweden. [PDF]
Virtanen M +7 more
europepmc +1 more source
This work introduces a theragenerative 3D‐printed biodegradable stent with Janus nanoarchitecture for spatially controlled vascular healing. A luminal tantalum ion–implanted surface accelerates endothelialization and hemocompatibility, while an abluminal sirolimus/poly‐L‐lactic acid–tantalum layer provides sustained drug release and suppresses smooth ...
Jong Hwa Seo +19 more
wiley +1 more source
The influence of social class of origin on labor market entry and the mediating role of education in Italy. [PDF]
Bussi D +3 more
europepmc +1 more source
A study on Volatility and Moving Average Timing Strategies applied to the European Stock Market [PDF]
Carlos Nuno Martins Cerqueira
openalex
Learning Market Beliefs from Credit Ratings: Evidence from the Timing of Corporate Bond Issuances
Yi Dong +3 more
openalex +1 more source
Overview of the Japanese Rapid Introduction Premium as a drug pricing framework to enhance patient access to innovative drugs. [PDF]
Takamura K, Jinnai G, Niwa Y, Kondoh M.
europepmc +1 more source

